OR
LUNG icon

Olympiad Research’s Pulmonx LUNG Stock Holding History

Olympiad Research’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,012
Closed -$153K – 436
2023
Q4 		$153K Buy
+12,012
New +$125K 0.12% 296
2023
Q3 		– Sell
-13,210
Closed -$173K – 370
2023
Q2 		$173K Buy
+13,210
New +$162K 0.17% 231

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Olympiad Research's LUNG Position: Q1 2024 in Review

Olympiad Research sold out of Pulmonx (LUNG) in Q1 2024, closing a stake of 12,012 shares — an estimated $153K sold.

Olympiad Research first reported a position in LUNG in Q2 2023 and held it in 2 quarters. The position peaked at $173K in Q2 2023. 118 funds tracked by Wall St. Rank hold LUNG as of Q1 2024.

  • Olympiad Research reported no remaining Pulmonx position as of Q1 2024 after selling out during the quarter.
  • Olympiad Research sold 12,012 Pulmonx shares in Q1 2024, an estimated $153K.
  • Olympiad Research first reported a position in Pulmonx in Q2 2023 and held it in 2 quarters.
  • Olympiad Research's Pulmonx position peaked at $173K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q1 2024.

Based on Olympiad Research's 13F filing for Q1 2024, filed 13 May 2024.